Skip to main content
OpenTrials

Clinical trial condition

Endocrine Gland Neoplasms

Explore clinical trials studying Endocrine Gland Neoplasms. Study availability and eligibility vary by location and protocol.

6,086 public trials 1,368 recruiting studies
Refine in advanced search Browse all conditions

Endocrine Gland Neoplasms trial results

Completed

A Study to Evaluate the Efficacy and Safety of Simtuzumab Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma

NCT01472198

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Birmingham Hematology and Oncology Associates, LLC Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Central Hematology Oncology Medical Group, Inc. Alhambra, California, United States
  • Comprehensive Blood and Cancer Center Bakersfield, California, United States
View all 57 locations
View Trial Details
Completed

Efficacy and Safety of Pazopanib Monotherapy After First-line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Asian Women

NCT01227928

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +15 more
Locations
  • GSK Investigational Site Guangzhou, Guangdong, China
  • GSK Investigational Site Nanjing, Jiangsu, China
  • GSK Investigational Site Shenyang, Liaoning, China
  • GSK Investigational Site Jinan, Shandong, China
View all 15 locations
View Trial Details
Completed

Second-Line Treatment for Patients With Platinum-Sensitive Ovarian Cancer

NCT00090610

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • Florida Gynecologic Oncology Fort Myers, Florida, United States
  • Jupiter Medical Center-Gynecology Oncology and Gynecology Jupiter, Florida, United States
  • Florida Hospital/Gyn/Onc Department Orlando, Florida, United States
  • Hematology-Onc. Assoc. of The Quad Cities Bettendorf, Iowa, United States
View all 19 locations
View Trial Details
Completed

Everolimus for Patients With Relapsed/Refractory Germ Cell Cancer

NCT01242631

Conditions
Endocrine Gland Neoplasms, Endocrine System Diseases, Genital Diseases, +14 more
Locations
  • Vivantes Klinikum am Urban Berlin, Germany
  • Universitatsklinikum Essen Essen, Germany
  • Universitatsklinikum Hamburg-Eppendorf Hamburg, Germany
  • Hannover Medical School Hanover, Germany
View Trial Details

Related conditions